TP53 and neuroblastoma: Using an orthotopic murine model of neuroblastoma, they also demonstrated that RG7388 potently inhibits neuroblastoma tumor growth in xenografts derived from several p53 wild-type cell lines, and that this inhibitory effect is abrogated in p53 mutated/null tumors in vivo.